Search Results 1321-1330 of 18131 for monoclonal antibody
Prior anti-cancer monoclonal antibody (mAb) within 4 weeks prior to study Day 1 or not recovered from adverse events due to agents administered more than 4 ...
... resistant prostate cancer (mCRPC) · Monoclonal antibody medicines for cancer: How they work · Multiple myeloma · Myxofibrosarcoma · Neuroblastoma · No appetite?
Antibody-directed or immunoglobulin-based immune therapy or other monoclonal antibody therapies within 8 weeks prior to Screening;; Previous chronic (more ...
I'm Dr. Halena Gazelka. April is Donate Life month. When it comes to organ transplantation, patients with high levels of antibodies, also called highly ...
Antibody-drug conjugates are targeted cancer therapies. They deliver potent drugs directly into cancer cells while minimizing harm to healthy tissue. These ...
Previous severe hypersensitivity reaction to another monoclonal antibody (mAb). Active autoimmune disease or a documented history of autoimmune disease or ...
Immunotoxins, such as inotuzumab ozogamicin, are antibodies linked to a toxic substance and may help find cancer cells that express CD22 and kill them without ...
The purpose of this study is to determine the cellular and mechanistic basis of bone marrow hematopoietic dysfunction in untreated Monoclonal B Cell ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift doubles in impact to help more patients.